What happened to apaziquone after ODAC Denial?

These posts are absolutely shameful. You people are complaining about things from 10 years ago at different companies. This thread should come down.

 

Shady Raj's cronies are complaining.
This certifies the truth behind these posts. All crooks of SPPI deserves to go to jail. SPPI is a public company and anybody playing with public health, money or sentiment should go to jail.

Truth is Raj wants to be CEO forever so he has hired many 'D' grade shady employees like Anil, Gajanan, Russell, Pramod etc. Always doubt anything positive coming out of these guys coz they are all losers.

 

What do Gajanan really gets 220k+
I dont think he deserves more Tha. 140k which was his real pay at lantheus. If Raj is lying hi. Anything above 150k then surely its an idiotic move by Raj. Raj can easily get a great Biostat VP in around $250k in OC. That what most of great pharma companies in OC are paying. Raj just need to open up the position and talk to these guys himself before asking his bootlickers.

Raj really has no knowledge of this market and thus don't know whom to hire or not. He just goes per nepotism.

 

What ? Giving Russell London 100k Raj has really gone nuts. Guy was badly kicked out of AGN coz he never wanted to work and even messed up 3 crucial trials here. Many kept their patience with him but his bs never saw an end.

So, Nobody hired Russll for 3 years from 2007 to 2011 and then all mighty Raj did. Why ? God knowz.? I got news Russell is on their key projects like Rolantis, qapzola and Poziotinib which makes me chuckle. Never thought Raj will be so lunatic & idiotic in his approach.

 

U first correct your english. His name is Russell Kondo & not Russell London. All u said seems to be true but leave the old guy on his own man. He seems to be nice. Poor guy just wants to spend another 7-8 years here @ sppi until his retirement.

 

Bankrolling family and friends. Great gig

 

That's what Raj is doing. First he took $77 million cash bonus (from 2011 to 2013) apart from his hefty $2 mil salary each year. Then he f**ked tons of employees (mostly white Americans). Later he F**ked stockhders by taking loan by selling $125 million convertible bonds (all money with interest is still due on those converyible bonds). Recently in 2016 Raj diluted stocks and diluting existing shareholders. He is the most annoying and selfish person you will ever work for. Even all Indians working for him talks shit behind him including his office boys like Anil Hiteshi, Pramod Gupta, Shiv Kapoor etc.

 

Great point. I searched and failed finding any phase - I results or publication of this study? If anybody find it please post a link here?

 

FDA should be aware of shady data practices at spectrum. Taking the same failed data to FDA in a different way for a different drug combination does not change results and should be caught upfront. These people don't have any innovation or shame. They just use the same compoundd 20 times with a different vial and cork and wants to call it different for sales purpose. Shame Shame Shame.

Shame to whole √Biometric and √Clinical deartments. Sales is just a backend and not to be blamed.

 

Seems sppi is trying to fool FDA once more. All shady people like Biostat guy, Regulatory guy, Pramod, anil and Raj are to fool FDA once more by asking something they didnt do a trial on. If they suceed if fooling FDA , Raj will collect huge bonus once more. So creepy.

 

Oh yes, they are trying to cheat/play FDA by getting evomela or marqibo approved in a different dose formulation without doing a single patient trial and looking at drug regulator's history: it will be denied because of non standards and safety recollections.

 

Any insider news on what happened @ FDA. Sppi.folks went for 3 vials yo 1 vial formulation approval for marketing. Did FDA passed or said No?

 

Marqibo? 3 to 1 vial formulation for sales?

 

You have no clue. FDA almost always demands studies be done in humans and it'll be no different for Marqibo. As far as Evomela, you very much are clueless about its development future.

 

It's insider info. Keep it inside. In any case, FDA doesn't say Yes/No at Type A,B,C meetings. They give advise. Yes/No comes upon approval of the submission.

 

Rolantis to fail same like Apaziqone. Heard, same Indian guy is the Biostat on all Rolantis analysis parts. Very sad! Raj will also get voted down on this.

He needs a renown Biostat VP who can really speak experience and should keep his Indian clowns away from this.